Home » Topics » Disease categories and therapies » Immune

Immune
RSS

CYT005-AllQbG10 enters phase II house dust mite allergy trial

Dec. 9, 2004

In vitro effects of the novel immunomodulator MDP-C

Dec. 9, 2004

Certican approval extended to new E.U. member states

Dec. 7, 2004

Clinical benefits found for infliximab, pimecrolimus in Behcet's disease / News in Context

Dec. 2, 2004

Novartis researchers prepare parenteral formulations of mycophenolic acid

Nov. 30, 2004

New interferon shows potent antiviral and proliferative efficacy

Nov. 30, 2004

Pharming to seek GRAS registration of recombinant human lactoferrin

Nov. 29, 2004

Cannabinoid CB2 receptor modulators described in a patent

Nov. 23, 2004

Phase II results from Altastaph neonate study

Nov. 22, 2004

Vaxfectin enhances antimalarial plasmid DNA vaccines

Nov. 18, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...